| 制药企业上市药品风险管理体系初探 |
| |
| 引用本文： | 唐慧鑫,马爱霞,孙骏. 制药企业上市药品风险管理体系初探[J]. 中国药物警戒, 2008, 5(4) |
| |
| 作者姓名： | 唐慧鑫 马爱霞 孙骏 |
| |
| 作者单位： | 1. 中国药科大学国际医药商学院,江苏,南京,210009
2. 江苏省药品不良反应监测中心,江苏,南京,210002 |
| |
| 摘 要： | 运用药品风险及企业风险管理相关理论,提出制药企业内部药品风险管理运作模式。企业在药品风险管理中担当重要责任,应加强风险意识,变被动接受为主动预防,充分发挥风险管理体系防范风险、控制风险的作用。
|
| 关 键 词： | 制药企业 药品风险 风险管理 药品不良反应 |
Exploring of the Risk Management System on Post-market Drug in the Enterprise |
| |
| TANG Hui-xin,MA Ai-xia,SUN JunSchool of International Pharmaceutical Business,China Pharmaceutical University. Exploring of the Risk Management System on Post-market Drug in the Enterprise[J]. Chinese JOurnal of Pharmacovigilance, 2008, 5(4) |
| |
| Authors: | TANG Hui-xin MA Ai-xia SUN JunSchool of International Pharmaceutical Business China Pharmaceutical University |
| |
| Affiliation: | TANG Hui-xin1,MA Ai-xia1,SUN Jun21School of International Pharmaceutical Business,China Pharmaceutical University |
| |
| Abstract: | Applying drug risk and enterprise risk management(ERM) theory,the mode of drug risk man-agement in the enterprise is proposed.Enterprises have important responsibility in risk management.Enterprises should strengthen risk consciousness and develope the precaution and control function of risk management in order to prevent beforehand risk. |
| |
| Keywords: | pharmaceutical enterprise drug risk risk management adverse drug reaction |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
